较冷透析液温度对急性肾损伤延长间歇性肾脏替代治疗期间血流动力学稳定性的影响:一项初步研究
这项单中心前瞻性随机交叉初步研究纳入21例急性肾损伤行延长间歇性肾脏替代治疗的危重患者,共78次治疗(每臂39次),随机起始透析液温度35°C或37°C。主要终点为低血压事件数(收缩压下降≥20 mmHg、平均动脉压下降≥10 mmHg、超滤减少或升压药需求增加任一)。37°C组低血压事件数是较冷透析液组的2倍(1.49±1.12 vs 0.72±0.69;发生率比2.06;p≤0.0001)。较冷透析液治疗更可能达到处方超滤目标。作者认为预防肾脏替代治疗期间血流动力学不稳定有助于实现超滤目标,并可能有助于预防危重患者容量过负荷。
要点
- 在急性肾损伤行延长间歇性肾脏替代治疗的危重患者中,透析液温度37°C组低血压事件数为1.49±1.12,35°C组为0.72±0.69,发生率比2.06(p≤0.0001)。
- 低血压事件定义为收缩压下降≥20 mmHg、平均动脉压下降≥10 mmHg、超滤减少或升压药需求增加任一。
- 较冷透析液(35°C)治疗更可能达到处方超滤目标。
- 作者认为预防肾脏替代治疗期间血流动力学不稳定有助于实现超滤目标,并可能有助于预防危重患者容量过负荷。
适用人群与场景
- ICU及降阶梯病房中因急性肾损伤接受延长间歇性肾脏替代治疗的危重患者。
诊断标准与关键阈值
- 低血压事件定义为以下任一:收缩压下降≥20 mmHg、平均动脉压下降≥10 mmHg、超滤减少或升压药需求增加。
处置流程与药物剂量
- 随机起始延长间歇性肾脏替代治疗,透析液温度35°C或37°C。
研究设计与关键结果
- 单中心前瞻性随机交叉初步研究,21例患者共78次延长间歇性肾脏替代治疗(每臂39次)。
- 主要终点低血压事件数:37°C组1.49±1.12 vs 35°C组0.72±0.69,发生率比2.06(p≤0.0001),37°C组事件数为35°C组的2倍。
- 较冷透析液治疗更可能达到处方超滤目标。
证据类型、等级与局限
- 证据类型:单中心前瞻性随机交叉初步研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急性肾损伤行延长间歇性肾脏替代治疗的危重患者中,使用较冷透析液(35°C)可减少治疗期间低血压事件,并有助于达到超滤目标、可能有助于预防容量过负荷。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute kidney injury requiring renal replacement therapy is associated with high morbidity and mortality. Complications of renal replacement therapy include hemodynamic instability with ensuing shortened treatments, inadequate ultrafiltration, and delay in renal recovery. Studies have shown that lowering dialysate temperature in patients with end-stage renal disease is associated with a decrease in the frequency of intradialytic hypotension. However, data regarding mitigation of hypotension by lowering dialysate temperature in patients with acute kidney injury are scarce. We conducted a prospective, randomized, cross-over pilot study to evaluate the effect of lower dialysate temperature on hemodynamic status of critically ill patients with acute kidney injury during prolonged intermittent renal replacement therapy.
DESIGN: Single-center prospective, randomized, cross-over study.
SETTING: ICUs and a step down unit in a tertiary referral center.
PATIENTS: Acute kidney injury patients undergoing prolonged intermittent renal replacement therapy.
INTERVENTIONS: Participants were randomized to start prolonged intermittent renal replacement therapy with dialysate temperature of 35°C or dialysate temperature of 37°C.
MEASUREMENTS AND MAIN RESULTS: The primary endpoint was the number of hypotensive events, as defined by any of the following: decrease in systolic blood pressure greater than or equal to 20 mm Hg, decrease in mean arterial pressure greater than or equal to 10 mm Hg, decrease in ultrafiltration, or increase in vasopressor requirements. The number of events was analyzed by Poisson regression and other outcomes with repeated-measures analysis of variance. Twenty-one patients underwent a total of 78 prolonged intermittent renal replacement therapy sessions, 39 in each arm. The number of hypotensive events was twice as high during treatments with dialysate temperature of 37°C, compared with treatments with the cooler dialysate (1.49 ± 1.12 vs 0.72 ± 0.69; incidence rate ratio, 2.06; p ≤ 0.0001). Treatment sessions with cooler dialysate were more likely to reach prescribed ultrafiltration targets.
CONCLUSIONS: Patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy with cooler dialysate experienced significantly less hypotension during treatment. Prevention of hemodynamic instability during renal replacement therapy helped to achieve ultrafiltration goals and may help to prevent volume overload in critically ill patients.
参考来源
- Edrees FY, Katari S, Baty JD, et al. A Pilot Study Evaluating the Effect of Cooler Dialysate Temperature on Hemodynamic Stability During Prolonged Intermittent Renal Replacement Therapy in Acute Kidney Injury. Crit Care Med. 2019. PMID: 30394919. doi:10.1097/CCM.0000000000003508
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。